Clinical trial
Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With…
NCT00080457 · Encysive Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00080457 |
|---|---|
| Title | Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension |
| Official title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment With an Open-Label Bosentan Arm in Patients With Pulmonary Arterial Hypertension (PAH) |
| Lead sponsor | Encysive Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | sitaxsentan sodium |
| Enrollment | 240 |
| Start date | May 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Apr 5, 2004 |
| Last update posted | Nov 9, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: